Szuba A - Search Results

1

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.

Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP. Böger RH, et al. Among authors: szuba a. Circulation. 1998 Nov 3;98(18):1842-7. doi: 10.1161/01.cir.98.18.1842. Circulation. 1998. PMID: 9799202 Clinical Trial.

2

Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.

Stühlinger MC, Oka RK, Graf EE, Schmölzer I, Upson BM, Kapoor O, Szuba A, Malinow MR, Wascher TC, Pachinger O, Cooke JP. Stühlinger MC, et al. Among authors: szuba a. Circulation. 2003 Aug 26;108(8):933-8. doi: 10.1161/01.CIR.0000085067.55901.89. Epub 2003 Aug 11. Circulation. 2003. PMID: 12912818 Clinical Trial.

3

Thromboangiitis obliterans. An update on Buerger's disease.

Szuba A, Cooke JP. Szuba A, et al. West J Med. 1998 Apr;168(4):255-60. West J Med. 1998. PMID: 9584663 Free PMC article. Review.

4

Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin).

Rockson SG, Kramer P, Razavi M, Szuba A, Filardo S, Fitzgerald P, Cooke JP, Yousuf S, DeVault AR, Renschler MF, Adelman DC. Rockson SG, et al. Among authors: szuba a. Circulation. 2000 Nov 7;102(19):2322-4. doi: 10.1161/01.cir.102.19.2322. Circulation. 2000. PMID: 11067782 Clinical Trial.

5

Limb hemodynamics are not predictive of functional capacity in patients with PAD.

Szuba A, Oka RK, Harada R, Cooke JP. Szuba A, et al. Vasc Med. 2006 Nov;11(3):155-63. doi: 10.1177/1358863x06074828. Vasc Med. 2006. PMID: 17288121

6

A novel therapy for lymphedema complicated by lymphorrhea.

Szuba A, Cooke JP, Rockson SG. Szuba A, et al. Vasc Med. 1996;1(4):247-50. doi: 10.1177/1358863X9600100402. Vasc Med. 1996. PMID: 9552579

7

Images in vascular medicine. Phlegmasia coerulea dolens--venous gangrene.

Szuba A, Cooke JP, Rockson SG. Szuba A, et al. Vasc Med. 1998;3(1):29-31. doi: 10.1177/1358836X9800300106. Vasc Med. 1998. PMID: 9666529 No abstract available.

8

Fibroblast growth factor as therapy for critical limb ischemia: a case report.

Cooke JP, Bhatnagar R, Szuba A, Rockson SG. Cooke JP, et al. Among authors: szuba a. Vasc Med. 1999;4(2):89-91. doi: 10.1177/1358836X9900400206. Vasc Med. 1999. PMID: 10406455

9

A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease.

Oka RK, Szuba A, Giacomini JC, Cooke JP. Oka RK, et al. Among authors: szuba a. Vasc Med. 2005 Nov;10(4):265-74. doi: 10.1191/1358863x05vm637oa. Vasc Med. 2005. PMID: 16444855 Clinical Trial.

10

Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells.

Dulak J, Józkowicz A, Dembinska-Kiec A, Guevara I, Zdzienicka A, Zmudzinska-Grochot D, Florek I, Wójtowicz A, Szuba A, Cooke JP. Dulak J, et al. Among authors: szuba a. Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):659-66. doi: 10.1161/01.atv.20.3.659. Arterioscler Thromb Vasc Biol. 2000. PMID: 10712388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters